Show 1095: How Do You Cope with Changing Recommendations?

Heart Disease and Inflammation:

Is cholesterol the main problem leading to clogged arteries and heart attacks? It certainly is important, but a brand-new study suggests that inflammation may also be critical. The study was called CANTOS (for Canakinumab Antiinflammatory Thrombosis Outcome Study). Canakinumab (Ilaris) is a medication that is approved for treating inflammatory diseases such as juvenile idiopathic arthritis. Although it has no impact on cholesterol, it reduced heart attacks and strokes. Lead author Paul Ridker, MD, explains the findings.

Should You Cut Back on Salt?

We’ve long been told to cut back on salt. But should you really throw out your salt shaker and eat only low-sodium food? One researcher urges us not to go overboard. Sodium is an essential nutrient, and a stringent low-salt diet can have some unexpected complications.

What Do You Do About Changing Recommendations?

The advice on salt is not the only health guideline that may be under revision. Changing recommendations can be confusing. Do they drive you crazy?

New research suggests that saturated fat, for example, is not the dietary demon that doctors used to imagine. Instead, refined carbohydrates and sugar may be more dangerous. Is there enough evidence to consider changing recommendations on what we eat for good health?

Your Calls Are Welcome:

To share your pet peeve about changing recommendations from health experts or to ask Joe & Terry a question, tune in Saturday, September 23, 2017, from 7 to 8 AM EDT or call 1-888-472-3366. You can also reach us through email (radio@peoplespharmacy.com) or Twitter @peoplespharmacy.

This Week’s Guests:

Paul M. Ridker, MD, is the Eugene Braunwald Professor of Medicine at the Harvard Medical School. With a formal background in cardiovascular medicine and epidemiology, Dr. Ridker directs the Center for Cardiovascular Disease Prevention. That is a translational research unit at the Brigham and Women’s Hosptal in Boston. He is the primary investigator of the CANTOS trial, a large multicenter, randomized controlled trial testing the inflammation hypothesis for treating atherosclerosis. The paper was published in The New England Journal of Medicine on September 21, 2017.  You can learn more about his research here and here. The photo is of Dr. Ridker.

James DiNicolantonio, PharmD, is a cardiovascular research scientist at St. Luke Mid-American Heart Institute in Kansas City, MO. He is also associate editor of the cardiology journal BMJ Open Heart. He is author of The Salt Fix, and his website is: thesaltfix.com